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Abstract 
Basic cell penetrating peptides are tools for molecular cellular internalization of non 
membrane permeable molecules. Their uptake mechanisms involve energy-dependent and 
energy-independent pathways such as endocytosis, direct translocation or physical 
endocytosis. These mechanisms are ruled by both, the peptides physicochemical properties 
and structure and by the membrane lipids characteristics and organisation. Herein we used 
plasma membrane spheres and membrane models to study the membrane perturbations 
induced by three arginine-rich cell penetrating peptides. Nona-arginine (R9) and the 
amphipathic peptide RWRRWWRRW (RW9) induced positive membrane curvature in the 
form of buds and membrane tubes. Membranous tubes underwent rolling resulting in 
formation of multilamellar membrane particles at the surface of the plasma membrane 
spheres. The amphipathic peptides RW9 and RRWRRWWRRWWRRWRR (RW16) 
provoked lipid and membrane associated protein domain separation as well as changes in 
membrane fluidity and cholesterol redistribution. These data suggest that membrane domains 
separation and the formation of multilamellar membranous particles would be involved in 
arginine-rich cell penetrating peptides internalization. 
 
Keywords: Basic peptides; membrane curvature; membrane domains; membrane rolling; plasma 
membrane. 
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Abbreviations: CPP, Cell Penetratin Peptide; GUV, Giant Unilamellar Vesicle; LUV, Large 
Unilamellar Vesicle; PC, L-α-phosphatidylcholine; PE, L--phosphatidylethanolamine; PMS, Plasma 
Membrane Sphere; PS, L-α-glycerophosphatidyl-L-serine; Py-met-chol, pyrene-labelled methyl-
cholesterol; R9, nona-arinine; RW9, RWRRWWRRW; RW16, RRWRRWWRRWWRRWRR. 
 
1. Introduction 
The interaction of proteins and peptides with membranes usually provokes a biological 
response leading to activation of intracellular transport mechanisms, protein transduction and 
antimicrobial defence. Based on arginine-rich peptide properties, cell penetrating peptides 
(CPPs) have been developed to carry active molecules into the cytoplasm of eukaryotic cells 
(Mae and Langel, 2006, Murriel and Dowdy, 2006). It is generally considered that cellular 
delivery of basic peptides mainly results from two different molecular pathways: direct 
plasma membrane translocation and internalization by endocytosis with subsequent 
endosomal release into the cytoplasm (Duchardt et al., 2007, Lundin et al., 2008). Moreover, 
one peptide can use both pathways depending on its extracellular concentration (Alves et al., 
2011, Alves et al., 2008) or on temperature (Jiao et al., 2009). It has also been demonstrated 
that amphipathic and cationic peptides use different endocytic routes for cellular 
internalization (Lundin et al., 2008). Recently, it was shown that the formation of 
membranous particles at the cellular surface is involved in direct arginine-rich peptide 
penetration into the cytosol (Hirose et al., 2012), and that this phenomenon is favoured by 
hydrophobic groups on the peptides. Thus, peptide sequence and structure specificities 
determine the nature of peptide-membrane association and in fine the cellular uptake 
mechanisms. Therefore, the characterization of peptide-membrane interactions is essential to 
understand the membrane changes occurring during intracellular traffic and antimicrobial 
activity as well as the mechanisms of cellular uptake that will help to develop efficient vectors 
for future therapeutic delivery of molecules. 
As in vivo phenomena linked to peptide-membrane interactions are complex, work on 
membrane models allowed to study the biophysical mechanisms and the characterization of 
peptide structure and affinity for different membranes (Eiriksdottir et al., Maniti et al., 2010, 
Rydberg et al., 2012, Takechi et al., 2011, Walrant et al., 2012). Several studies showed that 
basic peptides are able to induce membrane negative curvature resulting in membrane 
invaginations in the form of vesicles and tubes as well as lipid phase separation (Alves et al., 
2008, Lamaziere et al., 2006, Lamaziere et al., 2009, Lamaziere et al., 2010, Lamaziere et al., 
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2008, Menger et al., 2003). These peptide-induced membrane deformations would result from 
changes in membrane asymmetry leading to changes in line tension and bending energy of 
membrane domains (Lipowsky, 1991, Lipowsky, 1993). Furthermore, insertion of polymers 
in the membrane increases bilayer asymmetry and produce positive membrane curvature 
resulting in budding and outward tubulation in Giant Unilamellar Vesicles (GUVs) (Tsafrir et 
al., 2003). The induction of positive or negative curvature by association of proteins to the 
membrane has been well established for the so called curvature sensing proteins containing 
Bar-like domains (Antonny, 2006, Dawson et al., 2006, Saarikangas et al., 2009). 
The study of cellular implications of peptide membrane-interactions requires the use of 
cellular models of the plasma membrane. Giant plasma membrane vesicles (GPMVs) or 
plasma membrane spheres (PMS) are promising models of biological membranes. These 
vesicles are void of cellular organelles and nuclear fragments (Scott, 1976) and their spherical 
morphology allows the observation of membrane deformations. Their molecular composition 
is representative of the plasma membrane. They contain intrinsic and extrinsic membrane 
proteins (Baumgart et al., 2007). Their overall lipid composition is typical of the plasma 
membrane containing  phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS) and phosphatidylinositols and, as for the plasma membrane, they are 
enriched on sphingomyelin (SM) and cholesterol (Fridriksson et al., 1999, Scott, 1976). Not 
only the global proportion of lipids is conserved but also the proportion of double bonds in 
acyl chains (Fridriksson et al., 1999). Only two anomalies have been reported: a decrease in 
phosphatidylinositol-bis-phosphate (Keller et al., 2009) and the loss of PS asymmetry 
(Baumgart et al., 2007, Keller et al., 2009, Lingwood et al., 2008). However, partial retention 
of lipid asymmetry has also been reported (Yavin and Zutra, 1979). PMS are able to undergo 
protein and phospholipid liquid ordered (Lo) and liquid disordered (Ld) phase separation 
(Baumgart et al., 2007, Keller et al., 2009, Levental et al., 2009, Levental et al., 2011, 
Lingwood et al., 2008), they are depleted of metabolic energy and membrane cytoskeleton 
elements are absent (Baumgart et al., 2007, Lingwood et al., 2008).  Recently they have been 
used to study the penetration of several basic cell penetrating peptides (Amand et al., 2011, 
Maniti et al., 2012, Saalik et al., 2011) and they allowed us to show peptide capacity to induce 
negative curvature with the consequent formation of plasma membrane invaginations 
(physical endocytosis) (Maniti et al., 2012). 
In the present study we used plasma membrane spheres to characterize the interaction of three 
different basic peptides with the plasma membrane. Nona-arginine (R9) that penetrate cells 
efficiently (Futaki et al., 2001, Mitchell et al., 2000, Wender et al., 2000), the amphypathic 
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peptide RWRRWWRRW (RW9) because it has been shown that the addition of hydrophobic 
groups and tryptophanes to polyarginines increase cell penetration (Futaki et al., 2001, Hirose 
et al., 2012, Rydberg et al., 2012), and RRWRRWWRRWWRRWRR (RW16) to study the 
effect of the length of an amphipathic peptide. We show that the association of small basic 
peptides with the plasma membrane results in the induction of positive curvature with 
subsequent vesicle bud formation and membrane tube elongation. Moreover, the membrane 
tubes underwent rolling and formed membranous particles attached to the plasma membrane 
surface. These effects were accompanied by changes in membrane fluidity, lipid domain 
separation and membrane-associated protein (annexin 2) redistribution. 
 
2. Material and Methods  
2.1. Materials. 
Nona-arginine (R9), RWRRWWRRW (RW9) and RRWRRWWRRWWRRWRR (RW16) 
where synthesized and purified as described (Lamaziere et al., 2007). Laurdan was from 
Molecular Probes, di-4-ANNEPDHQ (ANE) was obtained from Dr Leslie M. Loew 
(Connecticut, USA) and pyrene-labelled cholesterol (Py-met-chol) was a kind gift of Dr. 
André Lopez (Toulouse, France). Egg yolk L-α-phosphatidylcholine (PC), egg yolk L--
phosphatidylethanolamine (PE), brain L-α-glycerophosphatidyl-L-serine (PS) and cholesterol 
were purchased from Sigma-Aldrich. 
 
2.2. Plasma membrane spheres (PMS).  
Standard and Annexin 2-GFP transfected MDCK cells were cultured in 75 cm2 flasks in 
DMEM in standard conditions (Ayala-Sanmartin et al., 2004). Plasma membrane spheres 
were obtained by the method described in (Lingwood et al., 2008) adapted in (Maniti et al., 
2012). Briefly, PMS induction was performed by overnight incubation of cells with 1 ml of 
PMS buffer (1.5 mM CaCl2, 1.5 mM MgCl2, 5 mM Hepes, 1 mg ml
-1 glucose in PBS pH 7.4). 
After PMS formation, 1 ml of PMS buffer was added, the culture was agitated gently and the 
supernatant containing the PMS was recovered and centrifuged at 1 000 rpm for 15 min. in a 
standard Eppendorf centrifuge. The PMS were recovered in 100 µl of PBS and conserved at 
4°C for several hours. The experiments presented here were performed with 5 independent 
PMS preparations. 
 
2.3. Peptide-PMS incubations and treatments.  
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All preparations for microscopic observation were performed on µ-slide 8 well slides (Ibidi) 
containing 160 µl of freshly prepared PMS. For di-4-ANEPPDHQ labelling, a stock solution 
(200 mM) in ethanol was diluted in PBS. Then, 20 µl were added for a final 5 µM 
concentration. Peptides were added in 10 µl for a final 10 µM concentration. For experiments 
in hypertonic solution, 20 or 40 µl of sucrose (500 mM) were added to attain a final 
concentration of 50 and 100 mM sucrose. 
 
2.4. Confocal microscopy.  
All confocal images were acquired with a TCS SP2 laser-scanning spectral system (Leica, 
Wetzlar, Germany) attached to a Leica DMR inverted microscope. Optical sections were 
recorded with a 63/1.4 or 100/1.4 immersion objectives. We systematically performed 30 
confocal slices for each PMS analysed. Considering that most of the PMS were in the range of 
15-20 μm, the acquisition of 30 slices allowed the observation of the PMS surface by steps of 
500 to 700 nm. Images stacking and 3D-projections were obtained using ImageJ software 
(NIH). For di-4-ANEPPDHQ imaging, the samples were excited at 488 nm (Ar ion laser) and 
the fluorescence emission was collected at 570-590 nm for the liquid ordered (Lo) 
contribution and at 620-640 nm for the liquid disordered (Ld) contribution. Imaging of 
Annexin 2-GFP was performed by excitation at 488 nm and the emission light was collected 
at 500-520 nm. 
 
2.5. Quantification of plasma membrane deformations.  
The quantification of the different structures observed: tubes, rolled tubes, buds and 
deformations were performed by direct observation under the microscope. Protrusions were 
considered as tubes when the length was higher than the diameter. The experiments were 
performed two to four times. The number of PMS analyzed by direct microscopy was: 1656 
for the control PMS, 409 for R9, 1150 for the RW9 and 322 for the RW16 treatments. The 
number of PMS analyzed by random confocal images were: 88 for the control PMS, 69 for 
R9, 96 for the RW9 and 69 for the RW16 treatments. The statistical significance was assessed 
by ANOVA with GraphPad Prism. * P<0.05, ** P<0.01, *** P<0.001. 
 
2.6. Large unilamellar vesicles.  
The appropriate amounts of lipids in a mixture of chloroform/methanol, 2/1 (v/v), were 
subjected to solvent evaporation under nitrogen. Four lipid compositions were used: PC/PS 
(75/25), PC/PS/cholesterol (50/25/25), PC/PS/PE (25/15/60) and PC/PS/PE/Cholesterol 
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(17/12/52/19) by weight. Depending on the fluorescence experiments Laurdan was added at 
0.1% weight, or Py-met-chol at 3% weight. Lipid films were hydrated with buffer (40 mM 
Hepes pH 7, 30 mM KCl, 1 mM EGTA) and vortexed extensively to obtain Multilamellar 
Vesicles (MLVs) at 1 mg/ml. Large Unilamellar Vesicles (LUV) were prepared by extrusion 
of MLVs through a polycarbonate filter (pore diameter 100 nm) as described (Zibouche et al., 
2008). 
 
2.7. Fluorescence spectrometry.  
Fluorescence spectra were acquired with a Cary fluorimeter (Varian) as described (Maniti et 
al., 2010). Temperature was regulated with a Peltier device and controlled by a thermocouple. 
The excitation and emission band-pass were set at 5 nm. The Laurdan emission spectra were 
recorded from 400 to 650 nm using 365 nm excitation. The Py-met-chol emission spectra 
were recorded from 365 to 600 nm using 330 nm excitation. Sequential recorded spectra 
were: first, 250 μl of buffer (10 mM Hepes pH 7.4) containing 5 μg LUVs, and second the 
LUVs 10 min. after peptides addition. Spectra were obtained by triplicate and the buffer 
background was subtracted. The spectra were normalized as 100% for the maximal emission 
intensity. Peptides were added to a 1:25 peptide:lipid weight ratio (1-2 μM final 
concentration). 
 
3. Results 
3.1.Basic peptides induce membrane budding, outward tubulation and tube rolling.  
The interaction with membrane lipids is a crucial step for cell penetrating peptides 
internalisation. Herein, we analysed peptide-induced membrane deformations using plasma 
membrane spheres (PMS) (Fig. 1a,b). We studied the efficient cell penetrating peptide R9, a 
variant with five arginine and 4 tryptophan residues and a longer variant (10 arginine and 6 
tryptophane residues). Fig. 1c-f shows that two arginine rich peptides, the fully positive (R9), 
and the amphipathic (RW9) induced plasma membrane outward budding. The number of buds 
per PMS and their size were variable ranging from one to more than ten and with a radius 
from about tenths of μm to several μm (see also supplementary Fig. S1). To characterize 
accurately the membrane topology of the small buds (external to the PMS), we systematically 
performed 30 confocal slices for each PMS (see methods). A confocal slice-sequence of a 
PMS incubated with RW9 showing the conservation of membrane continuity between the 
PMS and the buds is shown in Movie 1. 
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Besides the buds, a second type of membrane positive curvature protrusion was observed in 
the form of long tubes (Fig. 1g-h). Tubes were more frequently observed with the RW9 
peptide than with R9. Tube diameters were estimated in the range of ≤0.2 to 1 μm and their 
length varied from about 5 to more than 100 μm (see also Supplementary Fig. S2). The longer 
tubes seemed to be associated to PMS containing cellular rests and sometimes it was difficult 
to discern whether the tube grew from the PMS membrane or the cellular rests. We can 
assume that cellular rests may act as a reservoir for lipids that supply the growth of very long 
tubes. 
 
The evolution of tubes and buds is illustrated in Fig. 2. Membrane protrusions (buds and 
tubes) were observed after 15 min. of peptide incubation. Once the bud or the tube starts to 
grow at the membrane surface, the process continued for a variable time (from 2 to more than 
30 min.) (Fig. 2 and supplementary Figs. S1d, S2c). At the end of the growing process, the 
protrusions seemed to be stable. In fact we very rarely observed retraction of the buds or tubes 
for as long as four hours of observation. One example of retraction is shown in Fig. 2d. On the 
contrary,  many of the tubes experimented a rolling process. Fig. 2e and the left part of Fig. 2f 
show confocal reconstructions of PMS just at the end of the rolling of a tube. Notice the 
movement of the small circular membranes during rolling. In the right part of Fig. 2f it is 
shown the PMS at the end of the tube rolling process. Notice that the circular membranes do 
not move anymore. This phenomenon takes about one second making extremely difficult to 
capture it by confocal microscopy. One example of such phenomenon occurring during 
confocal slicing of a PMS is shown in Movie 2. 
  
The frequency of budding and tubulation in more than 3 800 PMS was quantified by 
microscopy. Not all control PMS were spherically perfect and sometimes bud-like structures 
were present. Fig. 3 shows that in control and in RW16 treated PMS about 13% of the 
vesicles presented small protrusions (buds or tubes). When incubated with R9 and RW9 about 
21 and 28% of PMS showed protrusions respectively. The statistical analysis revealed that 
RW9 was the more efficient peptide in provoking protrusions, preferentially tubes (16% of 
tubes, and 12% of buds), and that R9 was more efficient in provoking bud formation (15% of 
buds, and 6% of tubes) (Fig. 3). However, the number of tubes was underestimated because as 
described above, many tubes experimented rolling. Therefore some tubes present in R9 and in 
RW9 incubated PMS were not counted because we were not sure of the origin of small 
structures attached to the PMS surface and, for quantification, we considered only 
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unambiguous buds and extended tubes. Figure 3 show that the number of protrusions 
observed when PMS were incubated with the longer amphipathic peptide RW16 was smaller 
compared to RW9 indicating that the amphipathic peptide length is important for the 
induction of membrane positive curvature. 
 
The formation of membrane protrusions may be influenced by membrane tension. Therefore, 
because RW9 showed the most efficient induction of protrusions, we studied its budding 
capacity in PMS at lower membrane tension. To reduce membrane tension, prior to peptide 
addition, the PMS were incubated in a hypertonic sucrose solution (50 and 100 mM in PBS). 
As shown in Fig. 4b, RW9 was able to induce membrane budding very efficiently (high 
number of buds per PMS) indicating that a decrease in membrane tension favours peptide 
induced budding. At higher sucrose concentrations the PMS changed their morphology 
spontaneously precluding the analysis of peptide induced budding. 
 
All the precedent experiments were performed with PMS labelled with the fluorescent probe 
di-4-ANEPPDHQ (ANE). To verify that the peptide induced positive curvature effect was not 
due to the fluorescent probe insertion in the membrane, we added the RW9 peptide to PMS 
form cells transfected with the membrane binding protein Annexin 2-GFP (Anx2-GFP). The 
GFP fluorescence was therefore used as the membrane probe. Fig. 4d shows that RW9 was 
able to induce plasma membrane budding in the absence of the probe ANE. 
 
3.2. Membrane lipid and protein domain separation induced by basic peptides.  
When performing the experiments with Annexin 2-GFP derived PMS we noticed that in 
several cases the membrane distribution of Anx2-GFP was perturbed by RW9. As shown in 
Fig. 5a,b, and in Movie 3, RW9 induced a redistribution of Anx2-GFP in Anx2-rich and 
Anx2-poor membrane domains. Considering that annexin 2 is a protein that binds only acidic 
phosholipids and that it is present in different membrane domains, we investigated whether 
the protein separation in domains was accompanied by lipid redistribution. We used the 
capacity of the ANE probe to sense rigid and fluid domains by changes in fluorescence 
emission intensities at 570-590 and 620-640 nm respectively (Jin et al., 2006). This probe 
does not respond to inserted peptides and is thus a good probe for lipid packing (Dinic et al., 
2011). In the absence of peptide, small fluid and rigid domains co-exist in the PMS that 
cannot be easily distinguished and merging of the green (rigid) and red (fluid) fluorescence 
results in a quite homogeneous yellow colour. With R9 peptide we saw no evident changes in 
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the ratio of fluorescence intensities at 570-590 and 620-640 nm (membranes homogeneously 
coloured). With RW9 we observed changes in membrane fluidity in some PMS. In Fig. 2b the 
PMS core is yellowish by combination of green (570-590 nm ordered lipids contribution) and 
red (620-640 nm fluid lipids contribution), and the bud is greener indicating a more ordered 
membrane domain. With RW16 (Fig. 5d-e, supplementary Fig. S3 and in Movies 4 and 5), we 
observed stronger differences in the 570-590 and 620-640 nm contributions indicating an 
efficient separation of membrane lipid domains by RW16. 
 
To get more insight into the peptide induced lipid domain separation, we prepared large 
unilamellar vesicles labelled with Laurdan, a probe able to monitor lipid fluidity by spectral 
changes. The fluorescence intensities at the maximum emission wavelength in the ordered 
(440 nm) and disordered (490 nm) phases characterize the spectrum. In LUVs composed of 
PC alone, the peptides did not induce changes in membrane fluidity (not shown). However, 
and as shown in Fig. 5f, the addition of peptides in LUVs containing PS induced a relative 
increase of the ordered (440 nm) contribution. For LUVs containing cholesterol 
(PC/PS/cholesterol) a relative decrease of the fluid membrane contribution (490 nm) was 
observed (Fig. S4a). This effect indicates a global decrease of membrane fluidity after peptide 
binding. We tested other lipid compositions such as PC/PS/PE/cholesterol and the membrane 
rigidification effect (increase in the ordered contribution) was also observed (Fig. S4b). 
Notice that in line with the confocal microscopy data, RW16 showed the stronger capacity to 
reduce membrane fluidity. A second fluorescent probe (Pyrene-labelled cholesterol, Py-met-
chol) was used to monitor lipid redistribution. Py-met-chol is able to follow the cholesterol 
enrichment of a domain by the induction of a fluorescent signal (at 475 nm) corresponding to 
the packing of the probe as oligomers (excimers) (Le Guyader et al., 2007). We studied the 
effect of peptides on PC/PS/PE LUVs with and without cholesterol. Fig. 5g and Fig. S4c 
show that R9 and RW9 induced a small and a moderate reduction of Py-met-chol excimers 
respectively. The stronger effect was observed with RW16 which decreased the Py-met-chol 
dimerisation in membranes with and without cholesterol. Overall, these data demonstrate that 
the basic and, especially the amphipathic peptides, are able to induce lipid and protein 
redistribution on membranes. 
 
4. Discussion 
Direct interaction of molecules with membrane phospholipids can induce diverse membrane 
deformations with positive or negative curvature as has been shown for Bar and IBar proteins 
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respectively (Antonny, 2006, Saarikangas et al., 2009). Penetratin and other cell penetrating 
peptides and toxins were shown to induce negative curvature resulting in membrane 
invaginations on giant unilamellar vesicles (Lamaziere et al., 2007, Lamaziere et al., 2006, 
Lamaziere et al., 2008, Romer et al., 2007) and in plasma membrane spheres (Maniti et al., 
2012). Herein we studied three peptides; one short basic non structured (R9) and two 
structured as amphipathic helix, one short (RW9) and one longer (RW16) with different 
penetration efficacy. The peptide-membrane interaction was studied in LUVs of different 
composition and in PMS. PMS were used as a plasma membrane model. One important 
modification of the PMS compared to the plasma membrane of cells is that the PS asymmetry 
is perturbed inducing a high abnormal PS content at the extracellular surface. This fact would 
also modify the peptide behaviour compared to the plasma membrane. However, compared to 
LUVs and GUVs, the PMS, as mentioned in the introduction, contain all the membrane 
proteins absent in other models and the proportion of lipids and their modifications and 
molecular diversity are mostly conserved making of them, to our knowledge the closer model 
of a living cell plasma membrane. The data show that R9 and RW9 are able to induce positive 
curvature in plasma membrane spheres and that both peptides along with RW16 induce lipid 
domains reorganization and/or membrane fluidity reduction in PMS and/or LUVs. Each 
peptide showed particular behaviour indicating that there is a structural specificity of peptide 
activities and some tendencies were observed and quantified as statistically significant. R9 
induced preferentially budding, RW9 induced strong membrane budding and tubulation and 
RW16 showed the highest lipid domain separation activity. Strong changes in tension and 
geometry of membranes in the form of tubes rolling were also observed. It is interesting to 
note that recently it was shown that the direct penetration of polyarginine (R12) into cells is 
preceded by the formation of membrane particles structured in multilamellar stacks of about 1 
μm in diameter on the cellular surface (Hirose et al., 2012), and that the lysine rich peptide 
S4(13)-PV accumulates also at the cell surface in complex multilamellar structures (Cardoso 
et al., 2012). Our data suggest that the rolling of tubes observed could be the mechanism 
leading to multilamellar structures of about 1 μm that would explain the formation of 
membranous particles observed by others (Hirose et al., 2012) and (Cardoso et al., 2012)  and 
involved in cell penetration. Moreover, the amphipathic peptide RW9 was shown to be more 
efficient than R9 in tube formation, and as pointed in the Hirose's study (Hirose et al., 2012) 
membrane particles formation and cell penetration were increased by addition of hydrophobic 
groups to R12. After formation of multilamellar structures at the cell surface, the molecular 
mechanism for the final penetration into the cytosol (Hirose et al., 2012) remains unknown. 
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The authors also suggested that the induction of membrane phase separation upon particle 
formation may accelerate the peptide penetration into cells. This hypothesis is strongly 
supported by the membrane domain separation demonstrated in the present study. Overall, 
positive curvature induction will favour peptide penetration as supported by the fact that R9 
and RW9 which provoke stronger curvature are more efficiently internalized than RW16 (Jiao 
et al., 2009). Moreover, this point is supported by a recent study showing that the membrane 
positive curvature inducing peptide EPN18 increase the translocation of Alexa488-labeled R8 
(Pujals et al., 2013). 
What are the molecular mechanisms involved in these peptides-induced membrane changes? 
The electrostatic interaction of arginines with phospholipids forming guanidine hydrogen 
bonds seems to be the first step (Rothbard et al., 2004). This interaction would be stable for 
R9 that remains unstructured upon membrane binding. However, for the peptides RW9 and 
RW16, the folding as an amphipathic α-helix upon membrane binding (Eiriksdottir et al., 
Maniti et al., 2010, Rydberg et al., 2012, Takechi et al., 2011, Walrant et al., 2012) would 
induce an hydrophobic type of interaction involving snorkelling (Mishra and Palgunachari, 
1996) of the small RW9 helix, and deeper insertion into the bilayer for the longer peptide 
RW16.  
How positive curvature is induced by these peptides? Membrane budding can be produced by 
changes in the volume/membrane surface ratio by heating (Dobereiner et al., 1993, Mui et al., 
1995). However the differences observed in peptide behaviour cannot be explained by merely 
heating the samples. The curvature induction mechanism could be based in the increase of 
membrane bilayer asymmetry. The insertion of molecules in the external leaflet of the bilayer 
increases its mass and consequently the positive curvature as has been shown for polymers 
with hydrophobic groups (Tsafrir et al., 2003). A model of the differential peptides action on 
the membrane is schematized in Fig. 6. R9 will induce a small increase in asymmetry by its 
interaction with the phospholipid head groups. The induction of positive curvature by R9 does 
not need the formation of an amphipathic helix. This capacity to create positive curvature 
without significant membrane insertion is in agreement with a study showing that coating of 
proteins at the membrane surface without helix insertion into the bilayer can induce 
membrane tube formation (Stachowiak et al., 2010). RW9 folded as an amphipathic α-helix 
would snorkel into the external leaflet of the bilayer with a stronger increase in the external 
leaflet phospholipid spacing inducing higher curvature. This stronger curvature will favour 
the RW9-mediated formation of tubes with shorter diameter than buds. RW16 is also able to 
form an amphipathic α-helix and to snorkel, but being longer than RW9, it would be able to 
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insert into the bilayer perturbing and/or increasing also the internal leaflet mass and therefore 
inducing a small membrane asymmetry insufficient to provoke significant budding and 
tubulation. The stronger insertion of RW16 compared to the RW9 peptide is supported by two 
facts: first, the tryptophan spectral shift observed after membrane binding of RW16 is 
stronger than that of RW9 (Lamaziere et al., 2007) indicating a more hydrophobic 
environment for RW16, and second, that, on the contrary to RW9, RW16 is able to 
permeabilize the membranes inducing the formation of pores in living cells (Lamaziere et al., 
2007) and in DOPC and DOPC/DOPG LUVs (Jobin et al.). This membrane permeabilisation 
would indicate a deeper perturbing interaction of RW16 compared to RW9. The exact 
mechanism for this behaviour is not known at present but we can speculate that to allow 
membrane insertion of the amphipathic helix RW16 molecules will associate by their 
arginines thanks to ionic bridges. This peptide aggregation mediated hypothesis is supported 
by the fact that RW16 induced membrane permeabilization in LUVs is cooperative (Jobin et 
al.). Therefore, the differential type of peptide membrane interaction creating different degree 
of asymmetry would produce weak or strong curvature (buds and/or tubes of different 
diameter).  
From a dynamic point of view, the most remarkable behaviour of membrane tubes was 
rolling. We suggest that rolling is determined by the capacity of the peptides to aggregate 
(Lamaziere et al., 2008, Stachowiak et al., 2010). Once the tube is homogeneously covered 
with the peptide inductor of positive curvature, the tube remains extended. The accumulation 
of the peptide in one side of the tube will result in a redistribution of the curvature effect. 
Positive curvature will concentrate on one side and the relaxation of the positive curvature 
(increase in negative curvature) in the opposite side of the tube will furnish the driving force 
for rolling (Fig. 6e). 
In precedent studies it was shown that short basic peptides were able to induce negative 
curvature in GUVs (Lamaziere et al., 2008). Herein, R9 and RW9 showed the capacity to 
induce positive curvature in PMS. Two factors would be responsible for the observed 
difference between GUVs and PMS. The first is that lipid complexity is stronger in PMS than 
in the GUVs. We previously show that the peptides were unable to induce negative curvature 
in Lo phases rich in sphingomyeline and cholesterol in GUVs [17]. The PMS contain higher 
contents of these lipids and therefore the capacity to induce negative curvature would be also 
reduced and the positive curvature by bilayer asymmetry (mass increase of the external 
leaflet) will be allowed. The second factor would be the presence of proteins in the PMS. The 
absence of proteins in GUVs would favour the movement and clusterization of the peptides 
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facilitating peptide-lipid reorganization competent for negative curvature. In PMS, the 
presence of proteins would reduce peptide diffusion and clusterization resulting in preferential 
membrane asymmetry (by mass increase) and positive curvature effects. 
Membrane domain separation was observed by redistribution of the membrane-associated 
protein annexin 2 as well as by separation of domains with different lipid packing (fluidity). 
What is the basis of the observed membrane domain separation? First, the different types of 
interaction (hydrogen bonding for R9, snorkelling for RW9 and bilayer insertion for RW16) 
with different affinities for phospholipids would result in specific membrane lipids 
redistribution (Fig. 6). The second factor is that membrane curvature by itself, may induce 
lipids redistribution as has been shown in GUV membrane tubes obtained by pulling or by 
photo-oxidation (Roux et al., 2005, Yuan et al., 2008). How peptide-induced lipids 
redistribution explain the segregation of annexin 2-rich and poor domains in the inner leaflet 
of the membrane? Molecular modelling suggested that complementary matching of lipids 
between the inner and the outer leaflet of the membrane take place (Stevens, 2005) and that 
disturbances of anchored membrane proteins in one leaflet, induce redistribution of proteins in 
the opposite leaflet (Yue and Zhang, 2012). It has also been demonstrated that cholera toxinB 
induced lipid separation in the external leaflet provokes redistribution of the cytosolic lipid 
bound protein Pal-Pal-mCFP (Lingwood et al., 2008). Moreover, it was experimentally shown 
that changes in one membrane leaflet composition were able to induce domain modification in 
the other leaflet (Collins and Keller, 2008). Therefore, by coupling between the outer and 
inner layers, the induced lipids redistribution in one side of the membrane might induce 
reorganization of lipids domains of different affinity for annexin 2 in the other side of the 
membrane.  
It is known that the membrane geometry and lipids domain separation is a very important 
factor in cell biology. These processes are involved in most of the membrane related functions 
especially in vesicular and tubular intracellular transport (Ayala, 1994, Simons and Gerl, 
2010, van Meer et al., 2008) and in peptide cell penetration by membrane particle formation 
at the cell surface (Hirose et al., 2012, Palm-Apergi et al., 2012). 
 
5. Conclusion 
In conclusion, basic cell penetrating peptides are able to penetrate cells by different 
mechanisms: by direct crossing of the plasma membrane, by metabolic endocytosis and by 
"physical endocytosis" if negative curvature is allowed. In this report we show that basic cell 
penetrating peptide induce membrane domain reorganization, membrane positive curvature 
14 
 
and the formation of multilamellar membranous particles formed by membrane rolling. These 
properties should have implications for peptide-mediated intracellular delivery by formation 
of membranous structures at the cell surface. 
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Figures legends 
 
Fig. 1 Basic peptides induce membrane protrusions on PMS. Confocal images of PMS labelled with 
the fluorescent probe di-4-ANEPPDHQ. Peptide-free PMS at 15 (a) and 180 min. (b) after di-4-
ANEPPDHQ addition. PMS incubated with R9 (c,d), and RW9 (e,f). At the left of the panels are the 
projections of 30 confocal slices, and at right a selected slice. Notice that the apparent internal vesicles 
are buds from the plasma membrane. Some buds are pointed by arrows (see also movie 1). Membrane 
tubes from PMS after incubation with RW9 (g,h). Notice the different length and diameter of the 
membrane protrusions. Scale bars 10 μm 
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Fig. 2 Evolution of membrane protrusions of PMS after incubation with basic peptides. Confocal 
projections of PMS labelled with the fluorescent probe di-4-ANEPPDHQ. (a); PMS after incubation 
with R9 at 2 min. interval (left to right). Notice the internal tube (arrowhead) (see (Maniti et al., 
2012)). (b); PMS at 20 and 50 min. intervals (left to right) after RW9 addition. (c); PMS at 20 min. 
intervals (left to right) after incubation with RW9. The "shadows" of the tube in the central image 
(arrow) are due to tube mobility. (d); Tubes from one PMS at 90 min. interval (top to bottom) after 
RW9 addition. Notice that the proximal part of the tube attached to the PMS is thicker than the distal 
part of the tube. The arrow indicate the retraction of a tube. (e); A rolling tube on a PMS surface after 
RW9 incubation. (f); PMS incubated with RW9 at 2 min. interval (left to right). Notice in (e) and at 
the left of (f) the shadows during the movement of a tube at the end of the rolling process (arrow). At 
right of (f) the rolled tube remains stable. Scale bars 10 μm. 
 
 
 
Fig. 3 Frequency of membrane protrusions induced by basic peptides. In (a), bars represent the percent 
of spherical PMS (none) and the percent of PMS with buds or tubes (protrusions). In (b), bars 
represent the percent of PMS with buds or with tubes in the whole PMS population. 3 855 PMS were 
analyzed. Bars are the mean +/- SEM from 2 to 4 independent experiments. * P<0.05, ** P<0.01, *** 
P<0.001 
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Fig. 4 RW9-induced membrane budding in hypertonic solution and in the absence of lipid fluorescent 
probe. (a); Confocal images of peptide-free PMS labelled with the fluorescent probe di-4-
ANEPPDHQ 15 min. after sucrose addition. (b); PMS after RW9 incubation in 100 mM sucrose. (c); 
Confocal images of peptide-free PMS from Annexin 2-GFP transfected MDCK cells 90 min. after 
sample preparation under the microscope. Annexin 2-GFP is associated to the plasma membrane. (d); 
Annexin 2-GFP-PMS after RW9 incubation. At the left of the panels are the projections of 30 confocal 
slices, and at right a selected slice. Notice that the apparent internal vesicles are outward buds from the 
plasma membrane. Some buds are pointed by arrows. Scale bars 10 μm. 
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Fig. 5 Basic peptides provoke plasma membrane domain separation. Projections of 30 confocal slices 
from Anx 2-GFP-PMS incubated with RW9 (a,b). Notice the heterogeneous distribution of Anx 2-
GFP compared with the control in Fig. 4c. Annexin 2-GFP rich domains (arrows), Anx 2-GFP poor 
domains (arrowheads). c and d are projections of three consecutive confocal slices of PMS labelled 
with the probe di-4-ANEPPDHQ (c-d). The colours code for the preferentially ordered rigid domains 
(570-590 nm in green) and the preferentially fluid domains (620-640 nm in red). Peptide-free PMS 
after 180 min. of labelling (c). PMS after RW16 addition (d). Zoom of a confocal slice (e) showing the 
differences in colour intensities (preferential fluid domains arrows, preferential rigid domain 
arrowhead). See Movies 4 and 5. Scale bars 10 μm. (f); Normalized Laurdan spectra of PC/PS LUVs 
(75/25) at 37°C. The increase of the rigid-ordered contribution (440 nm) and the decrease of the fluid 
domain contribution (490 nm) are indicated by arrows. (g); Normalized Py-met-chol spectra of 
PC/PS/PE/Py-met-chol LUVs (25/15/60/3) at 23°C. The decrease of probe dimers contribution (475 
nm) is indicated by the arrow. LUVs (black lines), LUVs incubated with R9 (red dotted lines), RW9 
(green dashed lines) and RW16 (blue dash-dotted lines). 
 
 
 
Fig. 6 Schematic model of membrane morphological changes induced by basic peptide-lipid 
interaction. (a); Membrane bilayer before peptide interaction. (b); R9 (gray structures) interacts with 
the phospholipid head groups by guanidine hydrogen bonding creating a small separation between 
them. (c); The amphipathic α-helix of RW9 (small gray helix) is able to snorkel into the external 
leaflet creating stronger separation of phospholipids and thus stronger positive curvature. (d); The 
amphipathic α-helix of RW16 (long gray helix) is able to insert profoundly into the bilayer inducing a 
small change in membrane curvature. To allow membrane insertion of the amphipathic helix 
molecules of RW16 will associate by the arginines thanks to ionic salt bridges. Lipid domains 
separation is a consequence of specific peptide-lipid affinities. (e); Peptide redistribution as the driving 
force for rolling. Progressive accumulation of peptide in one side of the tube would change the 
positive curvature redistribution resulting in tube rolling and in formation of membranous multilayer 
structures at the cell surface. For more details see discussion 
 
